Quent Capital’s Halozyme HALO Stock Holding History

Quent Capital’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$16K	Buy	154 +29	+23%	+$2.8K	﹤0.01%	1194
2026 Q2	$9.8K	Sell	125 -10	-7%	-$682	﹤0.01%	1254
2026 Q1	$8.72K	Sell	135 -1	-0.7%	-$70	﹤0.01%	1185
2025 Q4	$9.15K	Sell	136 -12	-8%	-$807	﹤0.01%	1169
2025 Q3	$10.9K	Buy	+148	New	+$9.8K	﹤0.01%	994
2025 Q2	–	Sell	-105	Closed	-$6.7K	–	698
2025 Q1	$6.7K	Hold	105	–	–	﹤0.01%	967
2024 Q4	$5.02K	Hold	105	–	–	﹤0.01%	1036
2024 Q3	$6.01K	Hold	105	–	–	﹤0.01%	1072
2024 Q2	$5.5K	Hold	105	–	–	﹤0.01%	1068
2024 Q1	$4.27K	Hold	105	–	–	﹤0.01%	1139
2023 Q4	$3.88K	Hold	105	–	–	﹤0.01%	1111
2023 Q3	$4.01K	Buy	105 +26	+33%	+$1.06K	﹤0.01%	1093
2023 Q2	$2.85K	Buy	+79	New	+$2.7K	﹤0.01%	1144

Other funds holding HALO

Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return

Los Angeles Capital Management Los Angeles, California $29.2B AUM 33.64% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

Stephens Investment Management Group Houston, Texas $9.29B AUM 41.16% 1-Year Est. Return

GW&K Investment Management Boston, Massachusetts $11.8B AUM 29.45% 1-Year Est. Return

Quent Capital's HALO Position: Q3 2026 in Review

Quent Capital increased its Halozyme (HALO) stake by 23% in Q3 2026, buying an estimated $2.8K and bringing the position to 154 shares worth $16K. The position accounts for ﹤0.01% of the portfolio, ranked #1194.

Quent Capital first reported a position in HALO in Q2 2023 and has held it in 13 quarters since. 456 funds tracked by Wall St. Rank hold HALO as of Q3 2026.

Quent Capital held 154 shares of Halozyme worth $16K as of Q3 2026.
Quent Capital bought 29 Halozyme shares in Q3 2026, an estimated $2.8K.
Halozyme made up ﹤0.01% of Quent Capital's portfolio in Q3 2026, its #1194 holding.
Quent Capital first reported a position in Halozyme in Q2 2023 and has held it in 13 quarters since.
456 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.

Based on Quent Capital's 13F filing for Q3 2026, filed 9 Nov 2026.